261 related articles for article (PubMed ID: 27477323)
21. Basal ganglia-cortical structural connectivity in Huntington's disease.
Novak MJ; Seunarine KK; Gibbard CR; McColgan P; Draganski B; Friston K; Clark CA; Tabrizi SJ
Hum Brain Mapp; 2015 May; 36(5):1728-40. PubMed ID: 25640796
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
[TBL] [Abstract][Full Text] [Related]
23. In vivo characterization of white matter pathology in premanifest huntington's disease.
Zhang J; Gregory S; Scahill RI; Durr A; Thomas DL; Lehericy S; Rees G; Tabrizi SJ; Zhang H;
Ann Neurol; 2018 Oct; 84(4):497-504. PubMed ID: 30063250
[TBL] [Abstract][Full Text] [Related]
24. Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex.
Unschuld PG; Joel SE; Pekar JJ; Reading SA; Oishi K; McEntee J; Shanahan M; Bakker A; Margolis RL; Bassett SS; Rosenblatt A; Mori S; van Zijl PC; Ross CA; Redgrave GW
Psychiatry Res; 2012; 203(2-3):166-74. PubMed ID: 22974690
[TBL] [Abstract][Full Text] [Related]
25. White matter connectivity reflects clinical and cognitive status in Huntington's disease.
Poudel GR; Stout JC; Domínguez D JF; Salmon L; Churchyard A; Chua P; Georgiou-Karistianis N; Egan GF
Neurobiol Dis; 2014 May; 65():180-7. PubMed ID: 24480090
[TBL] [Abstract][Full Text] [Related]
26. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
[TBL] [Abstract][Full Text] [Related]
27. Progressive alterations in white matter microstructure across the timecourse of Huntington's disease.
Estevez-Fraga C; Elmalem MS; Papoutsi M; Durr A; Rees EM; Hobbs NZ; Roos RAC; Landwehrmeyer B; Leavitt BR; Langbehn DR; Scahill RI; Rees G; Tabrizi SJ; Gregory S
Brain Behav; 2023 Apr; 13(4):e2940. PubMed ID: 36917716
[TBL] [Abstract][Full Text] [Related]
28. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
[TBL] [Abstract][Full Text] [Related]
29. Myelin Breakdown in Human Huntington's Disease: Multi-Modal Evidence from Diffusion MRI and Quantitative Magnetization Transfer.
Bourbon-Teles J; Bells S; Jones DK; Coulthard E; Rosser A; Metzler-Baddeley C
Neuroscience; 2019 Apr; 403():79-92. PubMed ID: 28579146
[TBL] [Abstract][Full Text] [Related]
30. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
[TBL] [Abstract][Full Text] [Related]
31. Brain Regions Showing White Matter Loss in Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.
McColgan P; Gregory S; Seunarine KK; Razi A; Papoutsi M; Johnson E; Durr A; Roos RAC; Leavitt BR; Holmans P; Scahill RI; Clark CA; Rees G; Tabrizi SJ;
Biol Psychiatry; 2018 Mar; 83(5):456-465. PubMed ID: 29174593
[TBL] [Abstract][Full Text] [Related]
32. Whole-Brain Connectivity in a Large Study of Huntington's Disease Gene Mutation Carriers and Healthy Controls.
Espinoza FA; Turner JA; Vergara VM; Miller RL; Mennigen E; Liu J; Misiura MB; Ciarochi J; Johnson HJ; Long JD; Bockholt HJ; Magnotta VA; Paulsen JS; Calhoun VD
Brain Connect; 2018 Apr; 8(3):166-178. PubMed ID: 29291624
[TBL] [Abstract][Full Text] [Related]
33. Reduced striato-cortical and inhibitory transcallosal connectivity in the motor circuit of Huntington's disease patients.
Garcia-Gorro C; de Diego-Balaguer R; Martínez-Horta S; Pérez-Pérez J; Kulisevsky J; Rodríguez-Dechicha N; Vaquer I; Subira S; Calopa M; Muñoz E; Santacruz P; Ruiz-Idiago J; Mareca C; Caballol N; Camara E
Hum Brain Mapp; 2018 Jan; 39(1):54-71. PubMed ID: 28990240
[TBL] [Abstract][Full Text] [Related]
34. Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
Byrne LM; Rodrigues FB; Blennow K; Durr A; Leavitt BR; Roos RAC; Scahill RI; Tabrizi SJ; Zetterberg H; Langbehn D; Wild EJ
Lancet Neurol; 2017 Aug; 16(8):601-609. PubMed ID: 28601473
[TBL] [Abstract][Full Text] [Related]
35. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
[TBL] [Abstract][Full Text] [Related]
36. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
[TBL] [Abstract][Full Text] [Related]
37. Early white matter abnormalities, progressive brain pathology and motor deficits in a novel knock-in mouse model of Huntington's disease.
Jin J; Peng Q; Hou Z; Jiang M; Wang X; Langseth AJ; Tao M; Barker PB; Mori S; Bergles DE; Ross CA; Detloff PJ; Zhang J; Duan W
Hum Mol Genet; 2015 May; 24(9):2508-27. PubMed ID: 25609071
[TBL] [Abstract][Full Text] [Related]
38. Prefrontal executive function associated coupling relates to Huntington's disease stage.
Unschuld PG; Liu X; Shanahan M; Margolis RL; Bassett SS; Brandt J; Schretlen DJ; Redgrave GW; Hua J; Hock C; Reading SA; van Zijl PC; Pekar JJ; Ross CA
Cortex; 2013; 49(10):2661-73. PubMed ID: 23906595
[TBL] [Abstract][Full Text] [Related]
39. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
[TBL] [Abstract][Full Text] [Related]
40. Magnetization transfer imaging in 'premanifest' Huntington's disease.
Jurgens CK; Bos R; Luyendijk J; Witjes-Ané MN; van der Grond J; Middelkoop HA; Roos RA
J Neurol; 2010 Mar; 257(3):426-32. PubMed ID: 19823894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
